Login / Signup

Additive Interactions between Betulinic Acid and Two Taxanes in In Vitro Tests against Four Human Malignant Melanoma Cell Lines.

Paula Wróblewska-ŁuczkaJustyna CabajWeronika BąkJulia BargiełAneta GrabarskaAgnieszka GóralczykJarogniew J Luszczki
Published in: International journal of molecular sciences (2022)
The incidence of melanoma is steadily increasing worldwide. Melanoma is the most lethal skin cancer, and new therapeutic methods are being sought. Our research aimed to investigate the cytotoxic and antiproliferative effects of betulinic acid in vitro, used alone and in combination with taxanes (paclitaxel, docetaxel) in four melanoma cell lines. Isobolographic analysis allowed us to assess the interactions between these compounds. Betulinic acid had no cytotoxic effect on normal human keratinocyte HaCaT cells; the amount of LDH released by them was significantly lower compared to melanoma cell lines. The present study shows that betulinic acid significantly inhibits the growth of melanoma cell lines in vitro. The IC50 values of betulinic acid ranged from 2.21 µM to 15.94 µM against the four melanoma lines. Co-treatment of betulinic acid with paclitaxel or docetaxel generated desirable drug-drug interactions, such as an additive and additive with a tendency to synergy interactions.
Keyphrases
  • skin cancer
  • endothelial cells
  • induced apoptosis
  • emergency department
  • risk factors
  • induced pluripotent stem cells
  • cell death
  • signaling pathway
  • smoking cessation
  • replacement therapy
  • pi k akt